miRNAs in non-alcoholic fatty liver disease

被引:0
作者
Zhen He
Cheng Hu
Weiping Jia
机构
[1] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Shanghai Diabetes Institute, Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Clinical Center for Diabetes
来源
Frontiers of Medicine | 2016年 / 10卷
关键词
nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; hepatocellular carcinoma; miRNA;
D O I
暂无
中图分类号
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver cirrhosis and hepatocellular carcinoma and is a considerable threat to public health. miRNAs are important post-transcriptional regulators of gene expression, and the dysregulation of miRNAs is involved in various biological processes in the liver, including lipid homeostasis, inflammation, apoptosis, and cell proliferation. Recently, a number of studies have described the association between miRNAs and NAFLD progression and have shown that circulating miRNAs reflect histological changes in the liver. Therefore, circulating miRNAs have potential use for the evaluation of NAFLD severity. In this review, we discuss the involvement of miRNAs in NAFLD pathogenesis and the key role of miRNAs in the screening, diagnosis, and staging of NAFLD.
引用
收藏
页码:389 / 396
页数:7
相关论文
共 385 条
[1]  
Younossi ZM(2015)Global epidemiology of non-alcoholic fatty liver disease-metaanalytic assessment of prevalence, incidence and outcomes Hepatology 64 73-84
[2]  
Koenig AB(2011)Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults Aliment Pharmacol Ther 34 274-285
[3]  
Abdelatif D(2013)Current concepts and management approaches in nonalcoholic fatty liver disease Sci World J 2013 481893-910
[4]  
Fazel Y(2014)Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome Lancet Diabetes Endocrinol 2 901-202
[5]  
Henry L(2015)A concise review of non-alcoholic fatty liver disease Atherosclerosis 239 192-413
[6]  
Wymer M(2012)Micro-RNAs (miRNAs): genomic organisation, biogenesis and mode of action Cell Tissue Res 349 405-1443
[7]  
Vernon G(2012)MicroRNAs in liver disease Gastroenterology 142 1431-812
[8]  
Baranova A(2015)Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis Gut 64 800-1765
[9]  
Younossi ZM(2009)Differential expression of microRNAs in mouse liver under aberrant energy metabolic status J Lipid Res 50 1756-1820
[10]  
Attar BM(2008)Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression Hepatology 48 1810-1324